Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Sep 15, 2019; 11(9): 761-767
Published online Sep 15, 2019. doi: 10.4251/wjgo.v11.i9.761
Published online Sep 15, 2019. doi: 10.4251/wjgo.v11.i9.761
Figure 1 Contrasted computed tomography images.
A: Contrasted computed tomography scan before surgical biopsy. A hypoattenuating lesion with ill-defined margins was observed in the posterior lobe of the liver; B and C: Comparative contrasted computed tomography scan before (B), and after (C) 2 cycles of lapatinib and capecitabine treatment. Hepatic metastases were reduced in size and tumor emboli in inferior vena cava (arrow heads) was mostly disappeared with the therapy.
- Citation: Inagaki C, Maeda D, Kimura A, Otsuru T, Iwagami Y, Nishida N, Sakai D, Shitotsuki R, Yachida S, Doki Y, Satoh T. Gallbladder cancer harboring ERBB2 mutation on the primary and metastatic site: A case report. World J Gastrointest Oncol 2019; 11(9): 761-767
- URL: https://www.wjgnet.com/1948-5204/full/v11/i9/761.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i9.761